FLUENZ TETRA

This brand name is authorized in Austria, Croatia, Estonia, Finland, France, Ireland, Italy, Lithuania, Poland, Romania, UK.

Active ingredients

The drug FLUENZ TETRA contains a combination of these active pharmaceutical ingredients (APIs):

1	A/Victoria/4897/2022 (H1N1)pdm09-like strain (A/Norway/31694/2022, MEDI 369815)
	Read more about Influenza, live attenuated
2	A/Darwin/9/2021 (H3N2)-like strain (A/Norway/16606/2021, MEDI 355293)
	Read more about Influenza, live attenuated
3	B/Austria/1359417/2021-like strain (B/Austria/1359417/2021, MEDI 355292)
	Read more about Influenza, live attenuated
4	B/Phuket/3073/2013-like strain (B/Phuket/3073/2013, MEDI 306444)
	Read more about Influenza, live attenuated

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J07BB03	Influenza, live attenuated	J Antiinfectives for systemic use → J07 Vaccines → J07B Viral vaccines → J07BB Influenza vaccines
Discover more medicines within J07BB03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	1518656, 1518667, 1635904, 1660597
FI	Lääkealan turvallisuus- ja kehittämiskeskus	163358, 551586
FR	Base de données publique des médicaments	62818082
GB	Medicines & Healthcare Products Regulatory Agency	271143
IT	Agenzia del Farmaco	043173018, 043173020, 043173032, 043173044
LT	Valstybinė vaistų kontrolės tarnyba	1076197, 1076198
PL	Rejestru Produktów Leczniczych	100309734
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W64662002, W64662004